Legend Biotech Corp
NASDAQ:LEGN
Legend Biotech Corp
Total Liabilities
Legend Biotech Corp
Total Liabilities Peer Comparison
Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Legend Biotech Corp
NASDAQ:LEGN
|
Total Liabilities
$597.2m
|
CAGR 3-Years
69%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Total Liabilities
$140.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
19%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Liabilities
$38.8B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
10%
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Liabilities
$88B
|
CAGR 3-Years
18%
|
CAGR 5-Years
11%
|
CAGR 10-Years
7%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Liabilities
$5.4B
|
CAGR 3-Years
20%
|
CAGR 5-Years
24%
|
CAGR 10-Years
19%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Liabilities
$7.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
17%
|
CAGR 10-Years
22%
|
See Also
What is Legend Biotech Corp's Total Liabilities?
Total Liabilities
597.2m
USD
Based on the financial report for Dec 31, 2023, Legend Biotech Corp's Total Liabilities amounts to 597.2m USD.
What is Legend Biotech Corp's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
7%
Over the last year, the Total Liabilities growth was 2%. The average annual Total Liabilities growth rates for Legend Biotech Corp have been 69% over the past three years , 7% over the past five years .